121 related articles for article (PubMed ID: 36924894)
1. Charge-conversional click polyprodrug nanomedicine for targeted and synergistic cancer therapy.
Wang Y; Cong Y; Cai M; Liang X; Wang L; Zhou D
J Control Release; 2023 Apr; 356():567-579. PubMed ID: 36924894
[TBL] [Abstract][Full Text] [Related]
2. Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery.
Wang S; Zhang F; Yu G; Wang Z; Jacobson O; Ma Y; Tian R; Deng H; Yang W; Chen ZY; Chen X
Theranostics; 2020; 10(15):6629-6637. PubMed ID: 32550894
[TBL] [Abstract][Full Text] [Related]
3. Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy.
Yang K; Yang Z; Yu G; Nie Z; Wang R; Chen X
Adv Mater; 2022 Feb; 34(6):e2107434. PubMed ID: 34693571
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment.
Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R
Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
[TBL] [Abstract][Full Text] [Related]
6. Angiopep2-Conjugated Star-Shaped Polyprodrug Amphiphiles for Simultaneous Glioma-Targeting Therapy and MR Imaging.
Wang X; Liu G; Chen N; Wu J; Zhang J; Qian Y; Zhang L; Zhou D; Yu Y
ACS Appl Mater Interfaces; 2020 Mar; 12(10):12143-12154. PubMed ID: 32078286
[TBL] [Abstract][Full Text] [Related]
7. "Bottom-up" Construction of Multi-Polyprodrug-Arm Hyperbranched Amphiphiles for Cancer Therapy.
Sun P; Chen D; Deng H; Wang N; Huang P; Jin X; Zhu X
Bioconjug Chem; 2017 May; 28(5):1470-1480. PubMed ID: 28441015
[TBL] [Abstract][Full Text] [Related]
8. Smart Unimolecular Micelle-Based Polyprodrug with Dual-Redox Stimuli Response for Tumor Microenvironment: Enhanced in Vivo Delivery Efficiency and Tumor Penetration.
Bai S; Ma X; Shi X; Shao J; Zhang T; Wang Y; Cheng Y; Xue P; Kang Y; Xu Z
ACS Appl Mater Interfaces; 2019 Oct; 11(39):36130-36140. PubMed ID: 31490659
[TBL] [Abstract][Full Text] [Related]
9. A bottlebrush-architectured dextran polyprodrug as an acidity-responsive vector for enhanced chemotherapy efficiency.
Zhang T; Wang Y; Ma X; Hou C; Lv S; Jia D; Lu Y; Xue P; Kang Y; Xu Z
Biomater Sci; 2020 Jan; 8(1):473-484. PubMed ID: 31755481
[TBL] [Abstract][Full Text] [Related]
10. Light-activatable dual prodrug polymer nanoparticle for precise synergistic chemotherapy guided by drug-mediated computed tomography imaging.
Wang Z; Kuang G; Yu Z; Li A; Zhou D; Huang Y
Acta Biomater; 2019 Aug; 94():459-468. PubMed ID: 31128323
[TBL] [Abstract][Full Text] [Related]
11. Dynamic precise dual-drug-backboned nano-prodrugs for selective chemotherapy.
Yang L; Yan G; Wang S; Xu J; Fang Q; Xue Y; Yang L; Xu X; Tang R
Acta Biomater; 2021 Jul; 129():209-219. PubMed ID: 34022467
[TBL] [Abstract][Full Text] [Related]
12. A bio-responsive 6-mercaptopurine/doxorubicin based "Click Chemistry" polymeric prodrug for cancer therapy.
Liao J; Peng H; Wei X; Song Y; Liu C; Li D; Yin Y; Xiong X; Zheng H; Wang Q
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110461. PubMed ID: 31924029
[TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
Jiang Y; Zhou Y; Zhang CY; Fang T
Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
[TBL] [Abstract][Full Text] [Related]
14. Photoactivated polyprodrug nanoparticles for effective light-controlled Pt(iv) and siRNA codelivery to achieve synergistic cancer therapy.
Zhang Q; Kuang G; Zhou D; Qi Y; Wang M; Li X; Huang Y
J Mater Chem B; 2020 Jul; 8(27):5903-5911. PubMed ID: 32538396
[TBL] [Abstract][Full Text] [Related]
15. Dual-Sensitive Charge-Conversional Polymeric Prodrug for Efficient Codelivery of Demethylcantharidin and Doxorubicin.
Wu Y; Zhou D; Zhang Q; Xie Z; Chen X; Jing X; Huang Y
Biomacromolecules; 2016 Aug; 17(8):2650-61. PubMed ID: 27384255
[TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Polyprodrug Amphiphile for Subcutaneous Xenograft Tumor Inhibition with Prolonged Acting Time In Vivo.
Chen D; Huang Y; Xu S; Jiang H; Wu J; Jin X; Zhu X
Macromol Biosci; 2017 Nov; 17(11):. PubMed ID: 28737832
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species-activatable camptothecin polyprodrug based dextran enhances chemotherapy efficacy by damaging mitochondria.
Zhang T; Ma X; Bai S; Wang Y; Zhang X; Lu Y; Wen F; Xue P; Kang Y; Xu Z
J Mater Chem B; 2020 Feb; 8(6):1245-1255. PubMed ID: 31957760
[TBL] [Abstract][Full Text] [Related]
18. Platinum(IV) complex-based two-in-one polyprodrug for a combinatorial chemo-photodynamic therapy.
Guo D; Xu S; Huang Y; Jiang H; Yasen W; Wang N; Su Y; Qian J; Li J; Zhang C; Zhu X
Biomaterials; 2018 Sep; 177():67-77. PubMed ID: 29885587
[TBL] [Abstract][Full Text] [Related]
19. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
Li Y; Lu H; Liang S; Xu S
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
[TBL] [Abstract][Full Text] [Related]
20. TME-Responsive Polyprodrug Micelles for Multistage Delivery of Doxorubicin with Improved Cancer Therapeutic Efficacy in Rodents.
Zhang S; Zhu P; He J; Dong S; Li P; Zhang CY; Ma T
Adv Healthc Mater; 2020 Sep; 9(18):e2000387. PubMed ID: 32815646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
